ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 963,61
0,62%
Dow Jones
38 225,66
0,85%
DAX
17 981,50
0,42%
Brent Oil
83,885
0,30%
Bitcoin
58 967,06
-0,26%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NeuroBo Pharmaceuticals Inc (NRBO)

  7. NeuroBo Pharmaceuticals Inc (NRBO) Actualités

NRBO NeuroBo Pharmaceuticals Inc

3,73
0,00 (0,00%)
Avant marché
Dernière mise à jour : 12:11:50
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NeuroBo Pharmaceuticals Inc NRBO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 3,73 12:11:50
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,73
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202414:01PRNUSNeuroBo to Present Latest Pre-Clinical Data on..
17/4/202414:05PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 1..
01/4/202414:01PRNUSNeuroBo Pharmaceuticals Completes Enrollment of Part 1 of..
28/3/202413:01PRNUSNeuroBo Pharmaceuticals Reports Year End 2023 Financial..
13/3/202413:01PRNUSNeuroBo Pharmaceuticals Receives Safety Review Committee..
04/3/202414:01PRNUSNeuroBo Pharmaceuticals Appoints Seasoned Life Science..
04/3/202413:30EDGAR2Form 8-K - Current report
29/2/202414:30EDGAR2Form 8-K - Current report
29/2/202414:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
14/2/202414:52EDGAR2Form 8-K - Current report
12/2/202414:01PRNUSNeuroBo Pharmaceuticals to Participate in the BIO CEO &..
01/2/202414:30EDGAR2Form 8-K - Current report
01/2/202414:01PRNUSNeuroBo Pharmaceuticals Announces FDA Clearance of IND for a..
18/1/202414:30EDGAR2Form 8-K - Current report
18/1/202414:01PRNUSNeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety..
09/1/202414:45EDGAR2Form 8-K - Current report
09/1/202414:30PRNUSNeuroBo Pharmaceuticals Regains Compliance with Nasdaq..
02/1/202414:01PRNUSNeuroBo to Participate in Industry and Investor Conferences..
28/12/202315:00EDGAR2Form 8-K - Current report
28/12/202314:45PRNUSNeuroBo Pharmaceuticals Submits IND Application to the FDA..
19/12/202315:03EDGAR2Form 8-K - Current report
19/12/202314:43PRNUSNeuroBo Pharmaceuticals Announces 1-for-8 Reverse Stock..
07/12/202315:20EDGAR2Form 8-K - Current report
01/12/202314:31PRNUSNeuroBo to Participate in Investor Conferences in December
13/11/202322:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:14EDGAR2Form 8-K - Current report
13/11/202322:05PRNUSNeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial..
06/11/202314:20EDGAR2Form 8-K - Current report
06/11/202314:05PRNUSNeuroBo Pharmaceuticals Strengthens Board of Directors with..
30/10/202313:06EDGAR2Form 8-K - Current report
17/10/202314:01PRNUSNeuroBo to Present at the H.C. Wainwright 7th Annual NASH..
22/9/202314:03EDGAR2Form 8-K - Current report
19/9/202322:15EDGAR2Form 8-K - Current report
15/9/202314:11EDGAR2Form 8-K - Current report
15/9/202314:01PRNUSNeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a..
24/8/202322:15EDGAR2Form 8-K - Current report
14/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202314:18EDGAR2Form 8-K - Current report
14/8/202314:01PRNUSNEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF..
09/8/202322:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:20EDGAR2Form 8-K - Current report
09/8/202322:05PRNUSNeuroBo Pharmaceuticals Reports Second Quarter 2023..
08/8/202322:15EDGAR2Form 8-K - Current report
03/8/202314:15EDGAR2Form 8-K - Current report
03/8/202314:01PRNUSNeuroBo Pharmaceuticals Receives First Site IRB Approval for..
02/8/202314:01PRNUSNeuroBo Pharmaceuticals Enters Into Term Sheet With MThera..
28/7/202312:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202312:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202312:02EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
29/6/202314:36EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
NRBO
NeuroBo Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés